Post by Curium Pharma

Our new Oxford facility is officially open!  This important milestone follows the award of Manufacturing Import Authorisation (MIA) from the MHRA for PYLCLARI® in Oxford.    This means that we are now able to expand access to licensed prostate cancer diagnostics in the UK and reflects Curium's continued investment in healthcare innovation and patient care.     Ciril Faia, CEO of Curium International welcomed Lord Mayor of Oxford, Councillor Chewe Munkonge, and Lady Mayoress Carol Munkonge, alongside Professor Sabina Dizdarevic, President of the British Nuclear Medicine Society (BNMS), Dr Amy Eccles, Honorary Secretary of BNMS, Jilly Croasdale of University Hospitals Birmingham NHS Foundation Trust and former BNMS President.